Why Attend the IPF Summit for its 10th Anniversary Edition:
With a wave of late-stage readouts and new therapies redefining the IPF landscape, this year’s summit will spotlight the data, strategies, and innovations shaping the next generation of drug development.
Expect deep dives into emerging biology, biomarker-driven approaches, and evolving clinical trial design, alongside candid discussions on differentiation in an increasingly competitive market.
Join leading experts across discovery, translational, and clinical development to uncover where the field is heading, forge valuable partnerships, and gain the insights needed to accelerate your programs and deliver meaningful impact for patients.
Divide & Conquer
Despite significant clinical progress, with numerous candidates advancing through development, critical challenges persist across both clinical development and discovery biology. Addressing these complexities requires collaboration across the entire drug development continuum.
That’s why the 10th IPF Summit brings together stakeholders from discovery through to clinical, with a program meticulously shaped with subject matter experts across the field.
Not sure which content track to join for the 10th IPF Summit? Here’s a quick guide to help you choose:
Emerging Biology & Early Translation Track
Designed for CSOs, discovery scientists, preclinical researchers, and biology leaders, this track brings together experts across early-stage innovation. Join an intimate, discussion-led forum to explore novel targets, cutting-edge modalities, and the latest advances in in vivo and in vitro modelling, all with a focus on strengthening early translational success.
Late Translation & Clinical Track
Tailored for CMOs, clinical and translational leaders, and practicing clinicians, this track dives into the realities of advancing therapies through the clinic. Share perspectives on evolving trial design, endpoint selection, and patient stratification, while addressing the key challenges shaping IPF clinical development today.
For Commercial Leaders & Business Development Heads
With its intimate, senior-level audience, the IPF Summit provides a unique environment to stay ahead of a rapidly evolving landscape. Gain first-hand insight into competitor strategy and pipeline progress, while identifying opportunities to strategically position your assets, differentiate in an increasingly competitive market, and build high-value partnerships.
Brand New: ILD & PPF Focus Day
Designed for those looking to stay ahead of a rapidly evolving landscape, this dedicated focus day explores the nuances shaping the next wave of ILD and PPF drug development. Gain a deeper understanding of disease heterogeneity, emerging targets, and clinical positioning strategies to help expand therapeutic potential across broader patient populations, driving both meaningful patient impact and long-term commercial opportunity.
What's New?
For our 10th anniversary edition, we are thrilled to present:
Brand New Investor Panel
Brand New: Interstitial Lung Diseases & Progressive Pulmonary Fibrosis Focus Day
Explore the Full Event Guide
- Learn from 40+ Expert Speakers
- Brand-New ILD & PPF Focus Day dedicated to ILDs & PPF & the nuances of drug development
- Brand-New Investor Panel with insights into building conviction early on to generate real investor confidence & more
- Structured Dual-Tracked Content Days Covering Emerging Biology & Early Translation, as well as Late Translation & Clinical, to tackle the most pressing challenges at that stage of development
Attending Companies Include:
Explore the Brand-New Agenda
Hear the latest industry updates and gain exclusive insights during our packed discussion-led agenda.
Partner With the IPF Summit
Position yourself alongside other leading solution providers to ensure your brand is directly in front of IPF, ILD & PPF decision makers.
Join An Intimate Community Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during dedicated networking sessions.